Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Nicotinic receptor antagonists as treatments for nicotine abuse.

Crooks PA, Bardo MT, Dwoskin LP.

Adv Pharmacol. 2014;69:513-51. doi: 10.1016/B978-0-12-420118-7.00013-5. Review.

2.

A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.

Winhusen TM, Brigham GS, Kropp F, Lindblad R, Gardin JG 2nd, Penn P, Hodgkins C, Kelly TM, Douaihy A, McCann M, Love LD, DeGravelles E, Bachrach K, Sonne SC, Hiott B, Haynes L, Sharma G, Lewis DF, VanVeldhuisen P, Theobald J, Ghitza U.

J Clin Psychiatry. 2014 Apr;75(4):336-43. doi: 10.4088/JCP.13m08449.

3.

Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment.

Winhusen TM, Kropp F, Theobald J, Lewis DF.

Drug Alcohol Depend. 2014 Jan 1;134:391-5. doi: 10.1016/j.drugalcdep.2013.09.019. Epub 2013 Sep 27.

4.

A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence.

Winhusen TM, Adinoff B, Lewis DF, Brigham GS, Gardin JG 2nd, Sonne SC, Theobald J, Ghitza U.

Drug Alcohol Depend. 2013 Dec 15;133(3):845-51. doi: 10.1016/j.drugalcdep.2013.09.002. Epub 2013 Sep 11.

5.

Adapting smoking cessation treatment according to initial response to precessation nicotine patch.

Rose JE, Behm FM.

Am J Psychiatry. 2013 Aug;170(8):860-7. doi: 10.1176/appi.ajp.2013.12070919.

6.

Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Niaura R, Chander G, Hutton H, Stanton C.

Curr HIV/AIDS Rep. 2012 Dec;9(4):375-84. doi: 10.1007/s11904-012-0138-4. Review.

7.

Tobacco dependence counseling in a randomized multisite clinical trial.

Croghan IT, Trautman JA, Winhusen T, Ebbert JO, Kropp FB, Schroeder DR, Hurt RD.

Contemp Clin Trials. 2012 Jul;33(4):576-82. doi: 10.1016/j.cct.2012.02.014. Epub 2012 Mar 3.

8.

Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.

Winhusen T, Stitzer M, Woody G, Brigham G, Kropp F, Ghitza U, Lindblad R, Adinoff B, Green C, Sharma G, Somoza E.

Contemp Clin Trials. 2012 Jan;33(1):197-205. doi: 10.1016/j.cct.2011.09.018. Epub 2011 Oct 8.

9.

Recent publications by ochsner authors.

[No authors listed]

Ochsner J. 2003 Summer;5(3):38-41. No abstract available.

10.

Using extended cognitive behavioral treatment and medication to treat dependent smokers.

Hall SM, Humfleet GL, Muñoz RF, Reus VI, Prochaska JJ, Robbins JA.

Am J Public Health. 2011 Dec;101(12):2349-56. doi: 10.2105/AJPH.2010.300084. Epub 2011 Jun 8.

11.

Indolizidine (-)-235B' and related structural analogs: discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release.

Pivavarchyk M, Smith AM, Zhang Z, Zhou D, Wang X, Toyooka N, Tsuneki H, Sasaoka T, McIntosh JM, Crooks PA, Dwoskin LP.

Eur J Pharmacol. 2011 May 11;658(2-3):132-9. doi: 10.1016/j.ejphar.2011.02.018. Epub 2011 Mar 1.

12.

Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM.

J Clin Psychiatry. 2010 Dec;71(12):1680-8. doi: 10.4088/JCP.09m05089gry. Epub 2010 May 18.

13.

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB.

Arch Gen Psychiatry. 2009 Nov;66(11):1253-62. doi: 10.1001/archgenpsychiatry.2009.142. Erratum in: Arch Gen Psychiatry. 2010 Jan;67(1):77. Dosage error in article text.

14.

Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K.

Harm Reduct J. 2009 Sep 18;6:25. doi: 10.1186/1477-7517-6-25.

15.

Nicotinic receptor-based therapeutics and candidates for smoking cessation.

Dwoskin LP, Smith AM, Wooters TE, Zhang Z, Crooks PA, Bardo MT.

Biochem Pharmacol. 2009 Oct 1;78(7):732-43. doi: 10.1016/j.bcp.2009.06.002. Epub 2009 Jun 10. Review.

16.

A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.

Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA.

Nicotine Tob Res. 2009 Jul;11(7):859-67. doi: 10.1093/ntr/ntp077. Epub 2009 May 29.

17.

Extended treatment of older cigarette smokers.

Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ.

Addiction. 2009 Jun;104(6):1043-52. doi: 10.1111/j.1360-0443.2009.02548.x. Epub 2009 Apr 9. Erratum in: Addiction. 2011 Jun;106(6):1204.

18.

Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Dwoskin LP, Pivavarchyk M, Joyce BM, Neugebauer NM, Zheng G, Zhang Z, Bardo MT, Crooks PA.

Nebr Symp Motiv. 2009;55:31-63. No abstract available.

19.

Extended cognitive behavior therapy for cigarette smoking cessation.

Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M.

Addiction. 2008 Aug;103(8):1381-90. doi: 10.1111/j.1360-0443.2008.02273.x.

20.

Tobacco addiction.

Hatsukami DK, Stead LF, Gupta PC.

Lancet. 2008 Jun 14;371(9629):2027-38. doi: 10.1016/S0140-6736(08)60871-5. Review.

Supplemental Content

Support Center